Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Improving Antimicrobial Activity and Physico-Chemical Properties by Isosteric Replacement of 2-Aminothiazole with 2-Aminooxazole

M. Juhás, A. Bachtíková, DE. Nawrot, P. Hatoková, VSK. Pallabothula, A. Diepoltová, O. Janďourek, P. Bárta, K. Konečná, P. Paterová, V. Šesták, J. Zitko

. 2022 ; 15 (5) : . [pub] 20220506

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22017212

Grantová podpora
NU21-05-00482 Ministry of Health of the Czech Republic
CZ.02.2.69/0.0/0.0/19_073/0016935 Grant Schemes at CU

Antimicrobial drug resistance is currently one of the most critical health issues. Pathogens resistant to last-resort antibiotics are increasing, and very few effective antibacterial agents have been introduced in recent years. The promising drug candidates are often discontinued in the primary stages of the drug discovery pipeline due to their unspecific reactivity (PAINS), toxicity, insufficient stability, or low water solubility. In this work, we investigated a series of substituted N-oxazolyl- and N-thiazolylcarboxamides of various pyridinecarboxylic acids. Final compounds were tested against several microbial species. In general, oxazole-containing compounds showed high activity against mycobacteria, especially Mycobacterium tuberculosis (best MICH37Ra = 3.13 μg/mL), including the multidrug-resistant strains. Promising activities against various bacterial and fungal strains were also observed. None of the compounds was significantly cytotoxic against the HepG2 cell line. Experimental measurement of lipophilicity parameter log k'w and water solubility (log S) confirmed significantly (typically two orders in logarithmic scale) increased hydrophilicity/water solubility of oxazole derivatives in comparison with their thiazole isosteres. Mycobacterial β-ketoacyl-acyl carrier protein synthase III (FabH) was suggested as a probable target by molecular docking and molecular dynamics simulations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017212
003      
CZ-PrNML
005      
20220720100138.0
007      
ta
008      
220718s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ph15050580 $2 doi
035    __
$a (PubMed)35631406
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Juhás, Martin $u Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000218909082
245    10
$a Improving Antimicrobial Activity and Physico-Chemical Properties by Isosteric Replacement of 2-Aminothiazole with 2-Aminooxazole / $c M. Juhás, A. Bachtíková, DE. Nawrot, P. Hatoková, VSK. Pallabothula, A. Diepoltová, O. Janďourek, P. Bárta, K. Konečná, P. Paterová, V. Šesták, J. Zitko
520    9_
$a Antimicrobial drug resistance is currently one of the most critical health issues. Pathogens resistant to last-resort antibiotics are increasing, and very few effective antibacterial agents have been introduced in recent years. The promising drug candidates are often discontinued in the primary stages of the drug discovery pipeline due to their unspecific reactivity (PAINS), toxicity, insufficient stability, or low water solubility. In this work, we investigated a series of substituted N-oxazolyl- and N-thiazolylcarboxamides of various pyridinecarboxylic acids. Final compounds were tested against several microbial species. In general, oxazole-containing compounds showed high activity against mycobacteria, especially Mycobacterium tuberculosis (best MICH37Ra = 3.13 μg/mL), including the multidrug-resistant strains. Promising activities against various bacterial and fungal strains were also observed. None of the compounds was significantly cytotoxic against the HepG2 cell line. Experimental measurement of lipophilicity parameter log k'w and water solubility (log S) confirmed significantly (typically two orders in logarithmic scale) increased hydrophilicity/water solubility of oxazole derivatives in comparison with their thiazole isosteres. Mycobacterial β-ketoacyl-acyl carrier protein synthase III (FabH) was suggested as a probable target by molecular docking and molecular dynamics simulations.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bachtíková, Andrea $u Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic
700    1_
$a Nawrot, Daria Elżbieta $u Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000288581529
700    1_
$a Hatoková, Paulína $u Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/000000028075101X
700    1_
$a Pallabothula, Vinod Sukanth Kumar $u Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000233273078
700    1_
$a Diepoltová, Adéla $u Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000260492794
700    1_
$a Janďourek, Ondřej $u Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000346332062 $7 xx0230412
700    1_
$a Bárta, Pavel $u Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000154455658 $7 uk20211104475
700    1_
$a Konečná, Klára $u Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000156707767
700    1_
$a Paterová, Pavla $u Department of Clinical Microbiology, University Hospital Hradec Králové, Sokolská 581, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000301927345 $7 xx0138094
700    1_
$a Šesták, Vít $u Department of Clinical Biochemistry and Diagnostics, Faculty of Medicine in Hradec Králové, University Hospital, Sokolská 581, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000246882577
700    1_
$a Zitko, Jan $u Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000301049925 $7 xx0230408
773    0_
$w MED00184066 $t Pharmaceuticals (Basel, Switzerland) $x 1424-8247 $g Roč. 15, č. 5 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35631406 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220718 $b ABA008
991    __
$a 20220720100134 $b ABA008
999    __
$a ind $b bmc $g 1816490 $s 1168454
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 15 $c 5 $e 20220506 $i 1424-8247 $m Pharmaceuticals $n Pharmaceuticals (Basel) $x MED00184066
GRA    __
$a NU21-05-00482 $p Ministry of Health of the Czech Republic
GRA    __
$a CZ.02.2.69/0.0/0.0/19_073/0016935 $p Grant Schemes at CU
LZP    __
$a Pubmed-20220718

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...